Q: What is Arikayce used for?

Arikayce is used to treat Mycobacterium avium complex lung disease .

Q: How does Arikayce work?

How Arikayce Fights Infection Arikayce contains amikacin, an aminoglycoside antibiotic. It works by entering bacterial cells and binding to their ribosomes, which are the structures responsible for making proteins. When the medication binds to these ribosomes, the bacteria can no longer produce the essential proteins they need to grow, multiply, and maintain their structure. This disruption eventually leads to the death of the bacteria. Liposomal Technology The medication is unique because the amikacin is encapsulated in liposomes, which are microscopic spheres made of fat-like substances. This liposomal delivery system is designed to help the drug reach the lungs directly when inhaled. Once in the lungs, the liposomes are taken up by immune cells called macrophages, which are the same cells where the bacteria often live. This allows the medication to target the infection more effectively. Biofilm Penetration Certain bacteria, such as Mycobacterium avium complex (MAC), can create a protective layer called a biofilm. This layer often makes it difficult for standard antibiotics to reach the bacteria. The liposomal structure of Arikayce is intended to help the antibiotic penetrate these biofilms and reach the bacteria hidden within the lung tissue.

Q: What are the active ingredients in Arikayce?

The active ingredient in Arikayce is amikacin .

Q: What are the side effects of Arikayce?

Common side effects of Arikayce may include hoarseness , cough , fatigue , and others. Always consult with a healthcare professional about potential side effects.

Q: What drug class is Arikayce?

Arikayce belongs to the aminoglycoside antibiotic drug class.

Q: What is the dosage of Arikayce and how do I take it?

How to Use Arikayce Arikayce is a suspension that is inhaled through the mouth. It must only be used with the Lamira Nebulizer System. Do not use this medication with any other type of nebulizer or delivery device. Before using the medication, the vial should be shaken vigorously for at least 10 to 15 seconds until the liquid looks uniform and well-mixed. If the vial has been refrigerated, it should be allowed to reach room temperature before use. Do not use the medication if it is not at room temperature. General Dosing Information This medication is typically used once every day. It is important to use it at the same time each day to maintain a consistent level of medicine in your system. Follow the specific instructions provided with your nebulizer system for assembly, use, and cleaning. Each vial is for single use only; any leftover medication should be discarded after the dose is completed. Missed Dose If you miss a dose, take it as soon as you remember on the same day. If you do not remember until the following day, skip the missed dose and continue with your regular daily schedule. Do not use two doses at once to make up for a missed one.

Q: Is Arikayce safe during pregnancy and breastfeeding?

Pregnancy Arikayce belongs to a class of antibiotics known as aminoglycosides. These medications have the potential to cause harm to a developing fetus. Specifically, aminoglycosides can cross the placenta and may cause permanent, irreversible hearing loss in the unborn baby. While there are no adequate studies on the use of Arikayce specifically in pregnant women, the known risks associated with this class of drugs suggest that it should only be used during pregnancy if the potential benefit justifies the potential risk to the fetus. Breastfeeding It is not known whether Arikayce passes into human breast milk, how it affects milk production, or if it has any effects on a breastfed infant. Because of the potential for serious side effects in a nursing child, a decision should be made in consultation with a healthcare provider to either discontinue breastfeeding or discontinue the medication. This decision should take into account the importance of the drug to the mother's health. Consulting Your Doctor If you are pregnant, planning to become pregnant, or are breastfeeding, it is important to discuss your situation with a healthcare professional. They can provide guidance on the risks and benefits of continuing treatment with Arikayce during these times.

Q: What is the FDA approval status of Arikayce?

FDA Approval and Indications The U.S. Food and Drug Administration (FDA) approved Arikayce in 2018 for the treatment of Mycobacterium avium complex (MAC) lung disease. It is intended for use in adults as part of a combination antibacterial regimen when limited or no other treatment options are available. It was the first medication approved under the Limited Population Pathway for Antibacterial and Antifungal Drugs (LPAD pathway), which is designed for drugs that address unmet medical needs in specific patient groups. Accelerated Approval Status Arikayce was granted accelerated approval based on its ability to achieve sputum culture conversion, which means the bacteria are no longer detected in the patient's mucus. As part of this pathway, the FDA may require further clinical studies to confirm the drug's long-term clinical benefits, such as improvements in symptoms or lung function. Boxed Warning The FDA has issued a Boxed Warning for Arikayce due to the risk of serious respiratory adverse reactions. These complications can include: Hypersensitivity pneumonitis (inflammation of the lungs). Bronchospasm (tightening of the muscles in the airways). Worsening of underlying lung disease. Hemoptysis (coughing up blood). Due to these risks, healthcare providers typically monitor patients closely for new or worsening respiratory symptoms during treatment.

Question 1

What is Arikayce?

Accepted Answer

Arikayce is a medication that belongs to the aminoglycoside class of antibiotics. It works by binding to specific parts of bacteria to prevent them from producing the proteins they need to grow and multiply.

The primary purpose of this medication is to stop the growth of bacteria that cause infection. By inhibiting bacterial protein synthesis, it helps the body control the spread of the bacteria.

Question 2

What is Arikayce used for?

Accepted Answer

Arikayce is used to treat Mycobacterium avium complex lung disease.

Question 3

How does Arikayce work?

Accepted Answer

How Arikayce Fights Infection

Arikayce contains amikacin, an aminoglycoside antibiotic. It works by entering bacterial cells and binding to their ribosomes, which are the structures responsible for making proteins. When the medication binds to these ribosomes, the bacteria can no longer produce the essential proteins they need to grow, multiply, and maintain their structure. This disruption eventually leads to the death of the bacteria.

Liposomal Technology

The medication is unique because the amikacin is encapsulated in liposomes, which are microscopic spheres made of fat-like substances. This liposomal delivery system is designed to help the drug reach the lungs directly when inhaled. Once in the lungs, the liposomes are taken up by immune cells called macrophages, which are the same cells where the bacteria often live. This allows the medication to target the infection more effectively.

Biofilm Penetration

Certain bacteria, such as Mycobacterium avium complex (MAC), can create a protective layer called a biofilm. This layer often makes it difficult for standard antibiotics to reach the bacteria. The liposomal structure of Arikayce is intended to help the antibiotic penetrate these biofilms and reach the bacteria hidden within the lung tissue.

Question 4

What are the active ingredients in Arikayce?

Accepted Answer

The active ingredient in Arikayce is amikacin.

Question 5

What are the side effects of Arikayce?

Accepted Answer

Common side effects of Arikayce may include hoarseness, cough, fatigue, and others. Always consult with a healthcare professional about potential side effects.

Question 6

What drug class is Arikayce?

Accepted Answer

Arikayce belongs to the aminoglycoside antibiotic drug class.

Question 7

What is the dosage of Arikayce and how do I take it?

Accepted Answer

How to Use Arikayce

Arikayce is a suspension that is inhaled through the mouth. It must only be used with the Lamira Nebulizer System. Do not use this medication with any other type of nebulizer or delivery device.

Before using the medication, the vial should be shaken vigorously for at least 10 to 15 seconds until the liquid looks uniform and well-mixed. If the vial has been refrigerated, it should be allowed to reach room temperature before use. Do not use the medication if it is not at room temperature.

General Dosing Information

This medication is typically used once every day. It is important to use it at the same time each day to maintain a consistent level of medicine in your system. Follow the specific instructions provided with your nebulizer system for assembly, use, and cleaning. Each vial is for single use only; any leftover medication should be discarded after the dose is completed.

Missed Dose

If you miss a dose, take it as soon as you remember on the same day. If you do not remember until the following day, skip the missed dose and continue with your regular daily schedule. Do not use two doses at once to make up for a missed one.

Question 8

Is Arikayce safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

Arikayce belongs to a class of antibiotics known as aminoglycosides. These medications have the potential to cause harm to a developing fetus. Specifically, aminoglycosides can cross the placenta and may cause permanent, irreversible hearing loss in the unborn baby. While there are no adequate studies on the use of Arikayce specifically in pregnant women, the known risks associated with this class of drugs suggest that it should only be used during pregnancy if the potential benefit justifies the potential risk to the fetus.

Breastfeeding

It is not known whether Arikayce passes into human breast milk, how it affects milk production, or if it has any effects on a breastfed infant. Because of the potential for serious side effects in a nursing child, a decision should be made in consultation with a healthcare provider to either discontinue breastfeeding or discontinue the medication. This decision should take into account the importance of the drug to the mother's health.

Consulting Your Doctor

If you are pregnant, planning to become pregnant, or are breastfeeding, it is important to discuss your situation with a healthcare professional. They can provide guidance on the risks and benefits of continuing treatment with Arikayce during these times.

Question 9

What forms and strengths does Arikayce come in?

Accepted Answer

Arikayce is supplied as a sterile, liposomal inhalation suspension. This medication consists of the active ingredient contained within tiny particles called liposomes, which are suspended in a liquid.

The suspension is provided in vials. It is designed to be used only with the Lamira Nebulizer System. It should not be used with other nebulizers, and it is not intended for injection or oral consumption.

Question 10

What is the FDA approval status of Arikayce?

Accepted Answer

FDA Approval and Indications

The U.S. Food and Drug Administration (FDA) approved Arikayce in 2018 for the treatment of Mycobacterium avium complex (MAC) lung disease. It is intended for use in adults as part of a combination antibacterial regimen when limited or no other treatment options are available. It was the first medication approved under the Limited Population Pathway for Antibacterial and Antifungal Drugs (LPAD pathway), which is designed for drugs that address unmet medical needs in specific patient groups.

Accelerated Approval Status

Arikayce was granted accelerated approval based on its ability to achieve sputum culture conversion, which means the bacteria are no longer detected in the patient's mucus. As part of this pathway, the FDA may require further clinical studies to confirm the drug's long-term clinical benefits, such as improvements in symptoms or lung function.

Boxed Warning

The FDA has issued a Boxed Warning for Arikayce due to the risk of serious respiratory adverse reactions. These complications can include:

Hypersensitivity pneumonitis (inflammation of the lungs).
Bronchospasm (tightening of the muscles in the airways).
Worsening of underlying lung disease.
Hemoptysis (coughing up blood).

Due to these risks, healthcare providers typically monitor patients closely for new or worsening respiratory symptoms during treatment.

Question 11

What should I know about Arikayce and cost?

Accepted Answer

Insurance and Pharmacy Access

Arikayce is classified as a specialty medication. It is typically not stocked at local retail pharmacies and must be obtained through a specialty pharmacy. Most insurance plans, including Medicare and private insurance, provide coverage for the drug, but the specific out-of-pocket cost depends on the individual's plan benefits, such as copayments or coinsurance requirements.

Financial Assistance

The manufacturer offers a support program designed to help patients access the medication. This program may include:

Copay Assistance: Eligible patients with commercial insurance may qualify for copay cards to lower their monthly costs.
Insurance Navigation: Support staff can help clarify insurance coverage and assist with the prior authorization process.
Patient Assistance Programs: There may be programs available to provide the medication at no cost or a reduced cost for patients who meet specific financial eligibility criteria and lack adequate insurance coverage.

Patients are encouraged to contact their insurance provider or the specialty pharmacy to determine their specific coverage details and explore available financial aid options.

Arikayce

📋Overview

How It Works

Uses

Active Ingredients

Common Side Effects

Warnings & Precautions

Dosage

Pregnancy & Breastfeeding

Frequently Asked Questions

📚References

Found an Error?

Find Discounts for Arikayce

Hospitals.net Disclosure